BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company’s product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates....

Updated on Aug 18, 2010
BioMarin Pharmaceutical at CrunchBase
Joseph Loscalzo
V. Bryan Lawlis Board of Directors
Jeffrey H. Cooper Senior Vice President and Chief Financial Officer
Scott Harris Sr. Manager, Regulatory Affairs
Chuck Olson Management
Ansbert K. Gadicke Board of Directors

January, 2013

BioMarin Pharmaceutical acquired Zacharon Pharmaceuticals

BioMarin Acquires Zacharon Pharmaceuticals

August, 2010

BioMarin Pharmaceutical acquired Zystor for $115M

BioMarin snares orphan drug upstart in $115M buyout

October, 2009

BioMarin Pharmaceutical acquired Huxley Pharmaceuticals for $58.5M

BioMarin Acquires Huxley Pharmaceuticals, Inc.